>>Natural Products>>Msr-blue

Msr-blue

Catalog No.GC61553

Msr-blue는 100배 이상의 형광 증분을 갖는 메티오닌 설폭사이드 환원효소에 대한 최초의 턴온 형광 프로브입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Msr-blue Chemical Structure

Size 가격 재고 수량
5 mg
US$207.00
재고 있음
10 mg
US$324.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Msr-blue is a first turn-on fluorescent probe for methionine sulfoxide reductase with a more than 100-fold fluorescence increment. Msr-blue is used for monitoring the enzyme activity in live cells (Λex=340 nm, Λem=440 nm)[1].

Msr-blue is emited blue fluorescence after activation by methionine sulfoxide reductase A (Msr A). Msr-blue responded to Msr A in both a time- and dose-dependent manner, and more than a 100-fold increase in the emission is observed. Msr-blue is converted to its corresponding sulfide (15′) under catalysis by either the purified Msr A or a cell lysate[1]. The 6-OHDA-treated PC12 cells as a cellular model of Parkinson's disease (PD) is employed and applied Msr-blue to probe the function of Msrs in the cells. With the aid of Msr-blue, a decline of the Msr activity in a PD model was disclosed for the first time[1].

[1]. Liangwei Zhang, et al. A specific fluorescent probe reveals compromised activity of methionine sulfoxide reductases in Parkinson's disease. Chem Sci. 2017 Apr 1;8(4):2966-2972.

리뷰

Review for Msr-blue

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Msr-blue

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.